1,207 top medical experts on Mantle-Cell Lymphoma across 40 countries and 40 U.S. states, including 1,180 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mantle-Cell Lymphoma: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the cyclin D1 gene (genes, BCL-1).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Non-Hodgkin Lymphoma (2,378).
  4. Clinical Trials ClinicalTrials.gov : at least 517 including 71 Active, 235 Completed, 102 Recruiting
  5. Synonyms: Poorly-Differentiated Diffuse Lymphocytic Lymphoma, Centrocytic Small-Cell Lymphoma, Intermediate Differentiated Diffuse Lymphocytic Lymphoma, Poorly-Differentiated Diffuse Lymphocytic Lymphoma, Intermediate Lymphocytic Lymphoma, Centrocytic Small-Cell Lymphoma, Mantle-Zone Lymphoma


  

        

                    


    Computing Expert Listing ...

);